Royalty Pharma declares fourth quarter 2026 dividend
Globe Newswire•16/10/2026•08:00 ET
0
Key Highlights
- ➤Q4 2026 dividend $0.235 per Class A ordinary share
- ➤Payment scheduled for December 10, 2026
- ➤Shareholders of record November 13, 2026
NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2026 of $0.235 per Class A ordinary share.
The dividend will be paid on December 10, 2026, to shareholders of record at the close of business on November 13, 2026.
Get started
Create a free account to read the full story.